E Now That The FDA Approved Pfizer-BioNTech, Is This It For Vaccine Stocks?

This morning, something that most investors were expecting actually happened. Rumors had been abuzz with Pfizer (PFE) and BioNTech (BNTX) at the center of them. The expectation toward the end of the week last week was that the duo's COVID-19 vaccine would become the first to obtain real FDA approval. Sure enough, during the early morning hours of the market being open, the news was released that, in fact, the FDA approved their vaccine for use in those 16 and over. While the company continues pursuing an expanded approval for younger patient populations, the historic event markets a major milestone in the fight against the coronavirus. But does this mean all other companies developing a vaccine candidate should hang up their shoes and find something else to do? Absolutely not.

Medic, Hospital, Laboratory, Medical, Health, Doctor

Image Source: Pixabay

In fact, if you look at where Moderna (MRNA) and Johnson & Johnson (JNJ) are, both companies are in the process of following suit with Pfizer/BioNTech. Moderna, for example, is still completing rolling data submissions. You've also got to remember that there are always opportunities to "make a better mousetrap" so to speak. Tylenol isn't the only pain/fever reducer, Robitussin isn't the only caught suppressant, and Claritin isn't the only allergy medication. If there's one thing to take away from any conversation about biotech stocks, it's that any company with their hat in the ring is likely making a version of something they hope to be better than the currently available method. Yes, this also pertains to diseases that have yet to see a viable treatment developed.

The current COVID landscape also has different variations of "vaccine stocks". Some companies are developing treatments for prevention like Pfizer/BioNTech, Moderna, JnJ, Astra Zeneca (AZN), etc. While others are pushing for drug candidates used by already hospitalized patients. Then you've got a slew of biotechs focusing on the byproducts of the virus. Things like acute respiratory distress syndrome ("ARDS") and other long haul or "long COVID" symptoms.

1 2 3
View single page >> |
How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.